Oxford researchers start new trial on the use of anti-TNF to treat COVID-19 in care homes
We are hopeful that anti-TNF therapy, first identified by Professor Sir Marc Feldmann and the Trust’s President Professor Sir Ravinder Maini, might prove to be an effective treatment for patients with COVID-19. Read the full article here....
Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
Professors John Grainger and Tracy Hussell’s CIRCO study funded by the Kennedy Trust, which defines altered myeloid function in COVID-19 patients, has been published in Science Immunology. Read the full article here...